Press Releases

Global Market for DNA Vaccines to Reach $2.7 Billion in 2019; Clinical Vaccines Segment Surging at 81.2% CAGR

August 05, 2014

Wellesley, Mass., Aug 05, 2014 –BCC Research (www.bccresearch.com) reveals in its new report, DNA VACCINES: TECHNOLOGIES AND GLOBAL MARKETS, the global market for DNA vaccines is expected to grow to $2.7 billion by 2019, with a five-year compound annual growth rate (CAGR) of 54.8%. The clinical vaccines category, the largest and fastest-growing segment of this market, is surging at 81.2% CAGR.

Once a stable though unexciting sector of the pharmaceutical industry, vaccines are fast becoming an attractive growth opportunity.  DNA vaccines, which target a wide range of traditional pharmaceutical markets such as cancers, allergies, and infectious diseases, are an emerging vaccine platform within this changing paradigm.

With biotechnologies and nanotechnologies driving tremendous growth in DNA vaccine development, the clinical vaccines segment, which was valued at just $78 million in 2013, is expected to grow to $2.4 billion in 2019. Key to this growth is emerging delivery technologies that are demonstrating the higher efficacy in humans required for commercialization of DNA vaccines.

Consequently, research tools and animal health play a vital role in the development of the large, human vaccine applications. This segment is expected to reach $308 million by 2019, registering a significant CAGR of 11.1%.

“The diversity and number of clinical trials points toward initial introduction of products with significant market potential late in the forecast period,” says BCC Research biotechnology analyst Jon Evans. “These products, together with newly introduced therapeutic vaccines already on the market, will transform the future of the vaccine industry.”

Human clinical DNA vaccines represent the primary future market opportunity for this industry.  The momentum for commercialization of a human DNA vaccine is growing due to the inherent advantages of DNA vaccines over other vaccine formats and an emerging consensus within the vaccine industry that DNA vaccines are safe and efficacious in humans.

DNA VACCINES: TECHNOLOGIES AND GLOBAL MARKETS provides an overview of the global market for DNA vaccines and related research tools. It includes analyses of global market trends, with data from 2013, estimates for 2014, projections of CAGRs through 2019, and profiles of companies important in the industry.

SAMPLE FIGURE
GLOBAL VALUE OF DNA VACCINE MARKET BY APPLICATION, 2013–2019
($ MILLIONS)
To Contact us, click here  


Source: BCC Research

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.

DNA Vaccines: Technologies and Global Markets( BIO067B )
Publish Date:     

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.